Results 181 to 190 of about 25,718 (237)
Hemoglobin C Disease With Splenomegaly and With Factor II Mutation Gene Thrombophilia: A Case Report. [PDF]
Vázquez-Folch SJ +3 more
europepmc +1 more source
Lack of knowledge of thalassemia among non-medical university students in Saudi Arabia: a cross-sectional study. [PDF]
Alhusseini N +3 more
europepmc +1 more source
Understanding the Outcomes of Extracorporeal Membrane Oxygen Support in Patients With Sickle Cell Trait. [PDF]
Willsey KM +7 more
europepmc +1 more source
Pubertal Assessment and Growth in Patients With Hemoglobinopathies: A Longitudinal Multicenter Study on the Association With Ferritin Levels. [PDF]
Dülberg J +20 more
europepmc +1 more source
A Novel Alpha1-Variant (HBA1:c.-35T>C) Complexed With the First Reported Hb M-Saskatoon in the Chinese Population. [PDF]
Yang Y +5 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
2022
Hemoglobinopathies are a group of inherited blood disorders characterized by compromised hemoglobin function. Hemoglobin is a 64kDa protein, consisting of four globin polypeptides each containing one heme molecule; blood acquires its red color from this heme molecule.
Eugene Khandros, Janet L. Kwiatkowski
+4 more sources
Hemoglobinopathies are a group of inherited blood disorders characterized by compromised hemoglobin function. Hemoglobin is a 64kDa protein, consisting of four globin polypeptides each containing one heme molecule; blood acquires its red color from this heme molecule.
Eugene Khandros, Janet L. Kwiatkowski
+4 more sources
Hematology, 2003
AbstractThe outlook for patients with sickle cell disease has improved steadily during the last two decades. In spite of these improvements, curative therapies are currently available only to a small minority of patients. The main theme of this chapter is to describe new therapeutic options that are at different stages of development that might result ...
George F, Atweh +7 more
openaire +2 more sources
AbstractThe outlook for patients with sickle cell disease has improved steadily during the last two decades. In spite of these improvements, curative therapies are currently available only to a small minority of patients. The main theme of this chapter is to describe new therapeutic options that are at different stages of development that might result ...
George F, Atweh +7 more
openaire +2 more sources

